XXSS
GENERIC MADRID TRANSACTION SENT TO IB
16/01/2026
Voltar para busca
Dado oficial do USPTO
IMMUNOSCORE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
IMMUNOSCORE
ST13
US500000079124758Classe
1, 5, 9, 10, 42, 44
Pedido
79124758
Registro
4513051
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
17/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 42, 44
Data de depósito
10/08/2012
Data de registro
15/04/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/11/2024
Última transação
17/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
PARIS, FR
Examinador
AGOSTO,GISELLE MARIE
Localização atual
Historical data usage
Titulares e representantes
Titulares
INSERM (Institut National de la Santé etet de la Recherche Médicale)
INSERM; (Institut National de la Santé; et de la Recherche Médicale)
Representantes
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
[ Cultures of microorganisms other than for medical and veterinary use; diagnostic preparations of microorganisms for scientific purposes, for diagnostic purposes, and for laboratory or research use; chemical reagents other than for medical or veterinary use; biomolecule marking kits comprising reagents for scientific research; reagents for scientific applications; and antibodies for scientific use ]
Classe 5
[ Chemical reagents for medical or veterinary use; clinical medical reagents; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical use; cultures of microorganisms for medical or veterinary use; chemical, pharmaceutical and biological preparations for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; and antibodies for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments ]
Classe 9
[ Microscopes; scanners; computer programs recorded on software and data-computing software for the diagnosis of cancer and the evaluation of a patient's reaction time to cancer treatments; and image analysis software ]
Classe 10
[ Medical and diagnostic apparatus and instruments for the diagnosis of cancer and the evaluation of a patient's reaction time to cancer treatments; microscopes for medical use; high-resolution scanners for use in scientific and medical research; and tissue sample preparation devices for medical diagnostic uses, namely, detecting abnormal cancer cells ]
Classe 42
Research and development of pharmaceutical products; [ software design; software design and development; design, ] maintenance and updating of software [ ; software consultancy ]
Classe 44
Medical assistance; [ hospital services; ] health care; performing diagnosis of diseases, namely, cancer, and providing information in the field of cancer diagnosis
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
XXCR
GENERIC MADRID TRANSACTION CREATED
16/01/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/08/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
20/07/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
20/11/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
20/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/11/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
05/04/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
15/04/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
25/08/2022
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
13/06/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
19/03/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
19/03/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
14/03/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
14/07/2020
71AG
REGISTERED-SEC.71 ACCEPTED
14/07/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
25/06/2020
PR71
POST REGISTRATION ACTION MAILED - SEC.71
22/06/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/04/2020
ES71
TEAS SECTION 71 RECEIVED
16/03/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/12/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
15/04/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/01/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/12/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/09/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/08/2014
FIMP
FINAL DISPOSITION PROCESSED
25/08/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/07/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
15/04/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/01/2014
PUBO
PUBLISHED FOR OPPOSITION
28/01/2014
GPNX
NOTIFICATION PROCESSED BY IB
25/01/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/01/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/01/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/01/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
20/12/2013
ALIE
ASSIGNED TO LIE
19/12/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/12/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
16/12/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/12/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
16/12/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/12/2013
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/11/2013
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
13/11/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/09/2013
GNRT
NON-FINAL ACTION E-MAILED
13/09/2013
CNRT
NON-FINAL ACTION WRITTEN
13/09/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/08/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/08/2013
ALIE
ASSIGNED TO LIE
22/08/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/08/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/08/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/08/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/07/2013
RFNT
REFUSAL PROCESSED BY IB
11/03/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/02/2013
RFRR
REFUSAL PROCESSED BY MPU
21/02/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/02/2013
CNRT
NON-FINAL ACTION WRITTEN
20/02/2013
MAFR
APPLICATION FILING RECEIPT MAILED
19/02/2013
DOCK
ASSIGNED TO EXAMINER
13/02/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/02/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/02/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IMMUNOSCORE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.